Shamah Steven P, Sahakian Ara B, Chapman Christopher G, Buxbaum James L, Muniraj Thiruvengadam, Aslanian Harry A, Villa Edward, Cho Jaehoon, Haider Haider I, Waxman Irving, Siddiqui Uzma D
Center for Endoscopic Research and Therapeutics, University of Chicago Medicine, Chicago, IL, USA.
Division of Gastrointestinal and Liver Diseases, University of Southern California, Los Angeles, California, USA.
Endosc Ultrasound. 2022 Jan-Feb;11(1):53-58. doi: 10.4103/EUS-D-21-00030.
EUS-guided drainage of pancreatic fluid collections (PFCs) has been increasingly performed using lumen-apposing metal stents (LAMS). However, recent data have suggested higher adverse event rates with LAMS compared to double pigtail plastic stents (DPS) alone. To decrease risks, there has been anecdotal use of placing DPS through the LAMS. We aimed to determine whether the placement of DPS through cautery-enhanced LAMS at time of initial placement decreases adverse events or need for reintervention.
We performed a multicenter retrospective study between January 2015 and October 2017 examining patients who underwent EUS-guided drainage of pseudocysts (PP), walled-off necrosis (WON), and postsurgical fluid collection using a cautery enhanced LAMS with and without DPS.
There were 68 patients identified at 3 US tertiary referral centers: 44 PP (65%), 17 WON (25%), and 7 PFSC (10%). There were 35 patients with DPS placed through LAMS (Group 1) and 33 with LAMS alone (Group 2). Overall technical success was 100%, clinical success was 94%, and adverse events (bleeding, perforation, stent occlusion, and stent migration) occurred in 28% of patients. Subgroup analysis compared specific types of PFCs and occurrence of adverse events between each group with no significant difference detected in adverse event or reintervention rates.
This multicenter study of various types of PFCs requiring EUS-guided drainage demonstrates that deployment of DPS across cautery-enhanced LAMS at the time of initial drainage does not have a significant effect on clinical outcomes, adverse events, or need for reinterventions.
超声内镜引导下胰腺液体积聚(PFCs)引流越来越多地使用管腔贴附金属支架(LAMS)进行。然而,近期数据表明,与单独使用双猪尾塑料支架(DPS)相比,LAMS的不良事件发生率更高。为降低风险,有人尝试通过LAMS放置DPS。我们旨在确定在初次放置时通过烧灼增强型LAMS放置DPS是否能减少不良事件或再次干预的需求。
我们在2015年1月至2017年10月期间进行了一项多中心回顾性研究,研究对象为接受超声内镜引导下假性囊肿(PP)、包裹性坏死(WON)和术后液体积聚引流的患者,这些患者使用了带或不带DPS的烧灼增强型LAMS。
在美国3个三级转诊中心共识别出68例患者:44例PP(65%),17例WON(25%),7例PFSC(10%)。35例患者通过LAMS放置了DPS(第1组),33例仅使用LAMS(第2组)。总体技术成功率为100%,临床成功率为94%,28%的患者发生了不良事件(出血、穿孔、支架堵塞和支架移位)。亚组分析比较了每组中特定类型的PFCs以及不良事件的发生情况,在不良事件或再次干预率方面未发现显著差异。
这项针对各种需要超声内镜引导引流的PFCs的多中心研究表明,在初次引流时通过烧灼增强型LAMS放置DPS对临床结局、不良事件或再次干预的需求没有显著影响。